Jennifer Hall

Obesity Medicine in Wilmington, Delaware

Practice Details

Address
2417 Silverside Rd Ste 4
Wilmington, DE 19810
Geocoded location: 39.8077, -75.5142
Taxonomy
Obesity Medicine (Preventive Medicine)
Credential
LMT, BCBTMB
NPPES Enumeration
Listed with NPPES since 2021
Sole Proprietor
Yes
Provider Gender (NPPES)
Female
NPPES Record Updated
July 2021

About This Clinician

This clinician is enumerated under Obesity Medicine, a Preventive Medicine subspecialty focused specifically on the medical management of obesity — including behavioral counseling, nutrition, and pharmacotherapy such as GLP-1 receptor agonists. Obesity-medicine specialists in Wilmington are among the practices most likely to actively manage GLP-1 prescribing, though this registry entry does not confirm current prescribing practices.

Locally, this is 1 of 1 Obesity Medicine (Preventive Medicine) practice in Wilmington carrying this exact taxonomy in our directory.

What to expect at an Obesity Medicine visit

A first visit at an obesity-medicine practice generally centers on a medical work-up rather than a quick prescription. In broad terms, patients often encounter:

  • A weight and health history, BMI/body-composition review, and discussion of prior weight-loss attempts.
  • A conversation about treatment options — lifestyle changes, and where appropriate anti-obesity medications such as GLP-1 receptor agonists (semaglutide, tirzepatide).
  • Baseline labs (e.g. A1c, metabolic panel, lipids) to screen for diabetes and metabolic conditions before starting medication.
  • A cost and coverage discussion, since many commercial plans limit obesity-only GLP-1 coverage and may require prior authorization.

This is general guidance for obesity medicine practices, not a description of Jennifer Hall's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 302-463-6043.

GLP-1 access in Wilmington, Delaware

Adult obesity rate
33.9%
#17 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$215/mo
Typical Delaware telehealth cash price
Medicaid GLP-1 coverage
Diabetes only
Delaware Medicaid, obesity indication

About 33.9% of Delaware adults have obesity (BMI 30+), ranking the state #17 of 50 (CDC BRFSS). Our directory currently lists 34 GLP-1-relevant clinics in Wilmington. If a cash-pay route makes more sense, compounded semaglutide through Delaware telehealth averages about $215/mo — well below brand-name Wegovy or Zepbound.

Explore more Delaware options on the best Delaware GLP-1 providers page, browse every Wilmington listing in the Wilmington clinic directory, or read the Delaware Medicaid GLP-1 coverage & prior-authorization guide.

Related Practices in Wilmington

Other Wilmington listings in the same directory tier:

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to Delaware addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured Delaware telehealth partners:

Featured Partners · Wilmington

Featured GLP-1 providers serving Wilmington

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick

    Compounded from

    $249.99/mo

    Save $1,099.01/mo vs Wegovy
    Get started →
  2. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  4. Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  5. 8.2

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  6. Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →

See more Wilmington options on the Wilmington clinic directory, our Wilmington GLP-1 telehealth page, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Wilmington obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Jennifer Hall's specialty taxonomy but not the specific medications it prescribes or its current service menu. Jennifer Hall is listed under Obesity Medicine, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 302-463-6043 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Jennifer Hall's primary specialty on file is Obesity Medicine.
Jennifer Hall is located at 2417 Silverside Rd Ste 4, Wilmington, DE 19810. The phone number listed in the registry is 302-463-6043. Its full record is public in the CMS National Provider registry under NPI 1679144869.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Jennifer Hall is currently accepting new patients. Call the practice at 302-463-6043 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.